ATE279940T1 - Behandlung und prävention von helicobacter- infektionen - Google Patents

Behandlung und prävention von helicobacter- infektionen

Info

Publication number
ATE279940T1
ATE279940T1 AT95920717T AT95920717T ATE279940T1 AT E279940 T1 ATE279940 T1 AT E279940T1 AT 95920717 T AT95920717 T AT 95920717T AT 95920717 T AT95920717 T AT 95920717T AT E279940 T1 ATE279940 T1 AT E279940T1
Authority
AT
Austria
Prior art keywords
prevention
treatment
helicobacter infections
helicobacter
catalase enzyme
Prior art date
Application number
AT95920717T
Other languages
English (en)
Inventor
Christopher Vincent Doidge
Adrian Lee
Fiona Jane Radcliff
Stuart Lloyd Hazell
Original Assignee
Csl Ltd
Univ New South Wales
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csl Ltd, Univ New South Wales filed Critical Csl Ltd
Application granted granted Critical
Publication of ATE279940T1 publication Critical patent/ATE279940T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0065—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT95920717T 1994-06-08 1995-06-08 Behandlung und prävention von helicobacter- infektionen ATE279940T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPM6124A AUPM612494A0 (en) 1994-06-08 1994-06-08 Treatment or prevention of helicobacter infection
PCT/AU1995/000335 WO1995033482A1 (en) 1994-06-08 1995-06-08 Treatment and prevention of helicobacter infection

Publications (1)

Publication Number Publication Date
ATE279940T1 true ATE279940T1 (de) 2004-11-15

Family

ID=3780694

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95920717T ATE279940T1 (de) 1994-06-08 1995-06-08 Behandlung und prävention von helicobacter- infektionen

Country Status (9)

Country Link
US (3) US6005090A (de)
EP (1) EP0771214B1 (de)
JP (1) JPH10500958A (de)
KR (1) KR100368475B1 (de)
AT (1) ATE279940T1 (de)
AU (1) AUPM612494A0 (de)
DE (1) DE69533673T2 (de)
NZ (1) NZ287385A (de)
WO (1) WO1995033482A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290962B1 (en) * 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection
AUPM399594A0 (en) * 1994-02-21 1994-03-17 Csl Limited Antigenic preparation for treatment or prevention of helicobacter infection
AUPM612494A0 (en) * 1994-06-08 1994-06-30 Csl Limited Treatment or prevention of helicobacter infection
JPH10502365A (ja) * 1994-07-01 1998-03-03 リカン・リミテッド ヘリコバクタータンパク質およびワクチン
DE69636320T2 (de) * 1995-06-02 2007-07-26 Eisai R&D Management Co., Ltd. Helicobacter Polypeptide, deren Herstellung und Verwendung
EP0909323B1 (de) * 1996-01-04 2007-02-28 Novartis Vaccines and Diagnostics, Inc. Bakterioferritin aus helicobacter pylori
US6551779B1 (en) 1996-05-31 2003-04-22 Tosiro Sugiyama Helicobactor catalase nucleotide sequences, their production and use
US5939300A (en) * 1996-07-03 1999-08-17 Diversa Corporation Catalases
JP3430853B2 (ja) * 1997-04-11 2003-07-28 株式会社ゲン・コーポレーション 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤
JP2002512619A (ja) * 1997-04-30 2002-04-23 メリウクス オラバクス 横隔膜下からの全身経路に使用するための抗ヘリコバクターワクチン組成物、および粘膜／非経口複合免疫法
US6599509B2 (en) * 1997-09-02 2003-07-29 Massachusetts Institute Of Technology Compositions and methods comprising helicobacter antigens for treatment and prevention of inflammatory bowel disease
US20020151462A1 (en) * 1998-02-19 2002-10-17 Ling Lissolo Helicobacter pylori membrane proteins
US6585975B1 (en) * 1998-04-30 2003-07-01 Acambis, Inc. Use of Salmonella vectors for vaccination against helicobacter infection
AU770498B2 (en) * 1998-06-19 2004-02-26 Merieux Oravax LT and CT in parenteral immunization methods against helicobacter infection
EP1232392B2 (de) * 1999-10-12 2014-04-02 Oxoid (Ely) Limited Verbessertes verfahren zum nachweis von säure-resistenten bakterien der gattung helicobacter im stuhl
AUPQ347199A0 (en) 1999-10-15 1999-11-11 Csl Limited Novel polypeptide fragments
AU772513B2 (en) * 1999-10-15 2004-04-29 Csl Limited Polypeptide fragments comprising C-terminal portion of helicobacter catalase
BR0015145A (pt) * 1999-10-29 2002-07-16 Wakamoto Pharma Co Ltd Anticorpo monoclonal, hibridoma, método de imunoensaio e kit para diagnose
EP1301204A1 (de) * 2000-07-05 2003-04-16 Merieux OraVax SNC Immunologische kombinationen zur prophylaxe und therapie einer helicobacter pylori infektion
US20020107368A1 (en) * 2000-12-07 2002-08-08 Jing-Hui Tian Helicobacter proteins, gene sequences and uses thereof
WO2003018054A1 (en) * 2001-08-31 2003-03-06 Chiron Srl. Helicobacter pylori vaccination
CA2733836A1 (en) * 2011-03-09 2012-09-09 Coorga International Holding Ltd. Oral dietary supplementation for addressing of human canities
US9878020B2 (en) * 2011-04-07 2018-01-30 Histapharm Inc. Oral enzyme compositions for intestinal delivery
CN118267458B (zh) * 2024-03-14 2025-09-30 北京智飞绿竹生物制药有限公司 一种可预防幽门螺杆菌感染的omv疫苗及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2637612B1 (fr) * 1988-10-06 1993-09-10 Pasteur Institut Sequences de nucleotides codant pour une proteine a activite ureasique
US5234910A (en) * 1989-07-18 1993-08-10 University Hospital Acid inhibitor of bacterial origin
US5258178A (en) * 1990-07-30 1993-11-02 Abbott Laboratories Method and product for the treatment of gastric disease
SK55593A3 (en) * 1991-03-05 1993-10-06 Wellcome Found Expresion of recombinant proteins in attenuated bacteria
US5262156A (en) * 1991-08-12 1993-11-16 Hycor Biomedical, Inc. Antigenic compositions and their use for the detection of Helicobacter pylori
CA2117490C (en) * 1992-02-26 2009-01-06 Timothy L. Cover Purified vacuolating toxin from helicobacter pylori and methods to use same
MX9301706A (es) * 1992-04-13 1994-05-31 Oravax Inc Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
US5420014A (en) * 1992-04-30 1995-05-30 Auspharm International Ltd. Rapid in vitro test for helicobacter pylori using saliva
AU4924893A (en) * 1992-09-16 1994-04-12 Galagen, Inc. Antibody treatment of (helicobacter pylori)
US5972336A (en) * 1992-11-03 1999-10-26 Oravax Merieux Co. Urease-based vaccine against helicobacter infection
EP0716613B1 (de) * 1993-07-27 2003-07-09 Csl Limited Behandlung eines durch helicobakter verursachten gastroduodenalen krankheit
US6191268B1 (en) * 1993-12-17 2001-02-20 Dana-Farber Cancer Institute Compositions and methods relating to DNA mismatch repair genes
FR2719998B1 (fr) * 1994-04-08 1996-09-27 Pasteur Merieux Serums Vacc Composition immunisante anti-hélicobacter pylori à base de catalase.
AUPM612494A0 (en) * 1994-06-08 1994-06-30 Csl Limited Treatment or prevention of helicobacter infection
US5498528A (en) * 1994-06-10 1996-03-12 King; Wing Detection of helicobacter pylori
US5610060A (en) * 1994-06-24 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Isolated Helicobacter hepaticus
US5837240A (en) * 1995-04-28 1998-11-17 Oravax-Merieux Co. Multimeric, recombinant urease vaccine
AR003125A1 (es) * 1995-06-01 1998-07-08 Astra Ab Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la
DE69636320T2 (de) * 1995-06-02 2007-07-26 Eisai R&D Management Co., Ltd. Helicobacter Polypeptide, deren Herstellung und Verwendung
US5939300A (en) * 1996-07-03 1999-08-17 Diversa Corporation Catalases

Also Published As

Publication number Publication date
US6005090A (en) 1999-12-21
JPH10500958A (ja) 1998-01-27
EP0771214A4 (de) 1998-07-29
KR970703164A (ko) 1997-07-03
KR100368475B1 (ko) 2003-04-11
WO1995033482A1 (en) 1995-12-14
AUPM612494A0 (en) 1994-06-30
US6468545B1 (en) 2002-10-22
EP0771214B1 (de) 2004-10-20
NZ287385A (en) 1998-10-28
US6630582B1 (en) 2003-10-07
DE69533673D1 (de) 2004-11-25
DE69533673T2 (de) 2006-03-09
EP0771214A1 (de) 1997-05-07

Similar Documents

Publication Publication Date Title
DE69533673D1 (de) Behandlung und prävention von helicobacter-infektionen
ATE222930T1 (de) Antigene arznei zur behandlung oder vorbeugung
ATE229978T1 (de) Helicobacter proteine und impstoffe
IL153474A0 (en) Human papilloma virus treatment
EP0915648A4 (de)
RU94042386A (ru) Вакцина против гепатита, содержащая 3-0-дезацилированный монофосфорил-липида, применение антигена гепатита для получения препарата для лечения гепатита, способ лечения гепатита
EP0716613A4 (de) BEHANDLUNG EINES DURCH -i(HELICOBAKTER PYLORI) VERURSACHTEN GASTRODUODENALEN KRANKHEIT
ATE258057T1 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
HU9700023D0 (en) Pyridyl-thio-compounds, their application again helicobacter bacterium
WO2001040473A3 (en) Pseudomonas aeruginosa antigens
AU3439799A (en) Immunization against and treatment for infection by (h.pylori)
LU90378I2 (fr) Tetravac
ATE215084T1 (de) Imidazopyridin-azolidinone
AU673344B2 (en) Vaccines based on streptokinase
ATE108335T1 (de) Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen.
ATE132375T1 (de) Neuramidase und glulaktoseoxidase als vaccinadjuvans
CA2191440A1 (en) Treatment and prevention of helicobacter infection
NZ331674A (en) Use of antigenic preparations comprising Helicobacter catalase for treating or preventing Helicobacter infection
TW223019B (de)
SE9403861D0 (sv) Novel medicinal use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties